Publication Date: 2022-11-08
Practice Area: Patent Litigation
Industry: Pharmaceuticals
Court: U.S. District Court of Delaware
Judge: District Judge Connolly
Attorneys: For plaintiff: Daniel M. Silver, Alexandra M. Joyce, McCarter & English, LLP, Wilmington, DE; Daniel G. Brown, Rebecca Lynne Neubauer, Latham & Watkins LLP, Washington, DC; Kenneth G. Schuler, Marc N. Zubick, Alex Grabowski, Latham & Watkins LLP, Chicago, IL; Jennifer Koh, David F. Kowalski, Latham & Watkins LLP, San Diego, CA; Herman Yue, Latham & Watkins LLP, New York, NY for plaintiff.
for defendant: Neal C. Belgam, Eve H. Ormerod, Smith, Katzenstein & Jenkins LLP, Wilmington, DE; Constance S. Huttner, Paul S. St. Marie, Jr., Roy H. Wepner, Beth C. Finkelstein, Jason A. Lief, Windels Marx Lane & Mittendorf LLP, Madison, NJ; Kenneth L. Dorsey, Cortlan S. Hitch, Morris James LLP, Wilmington, DE; Deepro R. Mukerjee, Lance A. Soderstrom, Katten Muchin Rosenman LLP, New York, NY; Jitendra Malik, Joseph M. Janusz, Katten Muchin Rosenman LLP, Charlotte, NC; Christopher B. Ferenc, Katten Muchin Rosenman LLP, Washington, DC; Rachel L. Schweers, Rachel J. Schaub, Katten Muchin Rosenman LLP, Chicago, IL for defendants.
Case Number: 21-1256-CFC-JLH
New drug application did not infringe on patent describing "ready to use" pharmaceutical product where proposed products were not prepackaged and required substantial effort to prepare the drug for administration.